AFT Pharmaceuticals narrows 1H loss, sees return to profitability this year or next

Rebecca Howard
Wed, 22 Nov 2017

By Rebecca Howard Nov. 23 (BusinessDesk) - AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, narrowed its first-half loss and said it is still on track to return to profitability this financial year or the next as it increases the number of markets where its products are sold.  The Auckland-based company reported a net loss of $6.9 million, or 7 cents per share, in the six months to Sept. 30 from a loss of $11 million, or 40 cents, in the prior period. Operating revenue was $36.6 million versus $29.8 million in the prior p...
Markets
MARKET CLOSE: NZ shares rise as optimism over covid drug buoys Asia
Dan Brunskill | Mon, 13 Jul 2020

New Zealand shares joined a rally across Asia, as upbeat investor sentiment spilled over from Wall Street's close on Friday on optimism over a late-stage trial for a hopeful covid-19 treatment.  Th...

Law & Regulation
SFO probes Labour Party on donations
Victoria Young | Mon, 13 Jul 2020

The Serious Fraud Office has confirmed a fifth investigation into electoral funding, stating today it is looking into donations to the Labour Party.The agency said the probe relates to donations made...

Markets
NZ dollar little changed as global shares defy worsening covid news
Jenny Ruth | Mon, 13 Jul 2020

The New Zealand dollar was little changed as traders awaited further trend-setting information and as rising share markets were offset by Florida reporting a US record for new covid infections. The...

The role of private equity in the wake of COVID-19

As local covid-19 restrictions ease, a new business cycle is beginning in New Zealand.